Founded in 1991, the New Jersey Center for Biomaterials has prided itself on improving patient care and public health through the development of new biomaterials. With ongoing industrial partnerships, the Center strives to bridge the gap between scientific innovation and commercialization. Many of the world’s leading biotechnology and pharmaceutical companies are headquartered in New Jersey, many of whom have established a productive collaborative relationship with the Center.
Every day, more start-ups are formed and are eager to become a major factor within the ever-expanding industry. These local companies, as well as many across the nation and the globe, are a part of our integrated networks for biomedical innovation.
We are currently involved with a wide array of projects under service, materials transfer, and research agreements. We strive to deliver the highest quality research while providing the necessary confidentiality and protection of intellectual property rights, in addition to our utmost adherence to research integrity.
Our novel and patented biomaterials and biomedical technologies are key in the establishment of licensing agreements with several companies. Additionally, the Center is an integral part of Rutgers, The State University of New Jersey, allowing industrial scientists the opportunity for a high standard of consultation and access to the hands-on education a leading academic institution can provide. Our team includes of inventors, innovators, entrepreneurs, former senior executives, medical professionals and experienced research scientists. We welcome the industrial research community to join forces with us to develop the products of tomorrow and shape the future of health and personal care.